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Hepatotoxicidade induzida por Hypericum perforatum com possível associação a copaíba  
(Copaifera langsdorffii Desf): relato de caso
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ABSTRACT
We report a case of liver damage in an elderly patient after the 
use of herbal products of Hypericum perforatum and copaiba 
(Copaifera langsdorffii Desf). Hepatotoxicity related to Hypericum 
perforatum is anecdotally known, but for copaiba, widely used as 
anti-inflammatory, there is just experimental data in the national 
literature. This report aimed to draw attention to the possible toxic 
effects of this association as well as to the clinical recovery of the 
patient after discontinuing their use. There is a tendency to suspect 
of the action of drugs to justify a non-viral acute liver injury, because 
of the large number of drugs responsible for hepatotoxicity. There 
are experiments and clinical reports in the literature describing some 
herbal products, including Hypericum perforatum, as the causative 
agents of this aggression, and are considered innocuous and used 
with no restrictions. We must remember that adverse reactions also 
occur with these substances; hence, they should be investigated when 
collecting the patient´s history, for leading to severe liver failure.
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RESUMO
Relatamos um caso de dano hepático em paciente idosa após uso de 
produtos naturais à base de Hypericum perforatum e copaíba (Copaifera 
langsdorffii Desf). A hepatotoxicidade do Hypericum perforatum é 
conhecida por relatos, mas a respeito da copaíba, largamente usada 
como anti-inflamatório, há apenas dados experimentais na literatura 
nacional. Essa apresentação visou chamar a atenção para possível 
efeito tóxico dessa associação, bem como para a recuperação clínica 
da paciente após interrupção de seu uso. Há uma tendência de suspeitar 
sobre a ação de medicamentos para justificar a lesão hepática aguda 
não viral, em razão do grande número de fármacos responsáveis 
por hepatotoxicidade. A literatura tem publicado experimentos e 
relatos clínicos em que produtos fitoterápicos, inclusive Hypericum 
perforatum, são o agente causador dessa agressão, considerados 
inócuos e utilizados livremente. É preciso lembrar que reações adversas 
ocorrem também com essas substâncias, merecendo sua investigação 
na obtenção da anamnese, pela possibilidade de promoverem quadros 
graves de falência hepática.
Descritores: Doença hepática induzida por droga; Hypericum/efeitos 
adversos; Medicamentos fitoterápicos/efeitos adversos; Relatos de 
casos
INTRODUCTION
The liver metabolizes many medications and is therefore 
subject to drug-induced toxicity. Hepatotoxicity occurs 
due to direct action in case of tuberculostatic agents,(1) 
statins and paracetamol,(2) or it may be idiosyncratic and 
unexpected; it is an important clinical problem that may 
trigger liver failure, with fatal consequences, or patients 
may require urgent liver transplant.
The incidence of hepatotoxicity is considered 
underestimated since the use of some drugs is often 
omitted. It manifests as acute or chronic liver failure and 
represents the single cause in up to 30% of acute hepatitis, 
or it appears as cholestasis, steatosis or fibrosis. Over 
900 exogenous substances with hepatotoxic potential 
have been identified and there are also reports of 
herbaceous plants that can cause harm.(3-6)
Men use a large amount of foods, medications and 
dietary supplements derived from plants. Kennedy 
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and Wightman(7) revised the mechanisms of action of 
different phytotherapeutic agents: alkaloids (caffeine 
and nicotine), terpenes (ginkgo, ginseng, valerian and 
Melissa officinalis) and phenolic compounds (curcumin, 
isoflavone and Hypericum perforatum).
The acute clinical picture varies from no symptoms 
and abnormal laboratory findings found by chance to 
nausea, vomiting, abdominal pain, jaundice and acute 
hepatic failure, and it can overlap with preexisting liver 
diseases. The lesions are classified as hepatocellular, 
cholestatic, mixed or vascular. It is essential to ask 
about the use of medications to make diagnosis since 
there is no gold standard test, specific serum marker 
or histological profile to identify the cause of hepatic 
aggression.
Treatment consists of discontinuation of the suspected 
product, general precautions, relative rest and bland 
diet, in addition to monitoring liver function due to risk 
of progressing to hepatic failure.(8)
CASE REPORT
A 79-year-old female patient sought care for presenting 
jaundice for one month. Past history of hypothyroidism. 
She was on Hypericum perforatum, copaiba, levothyroxine, 
omega 3, glucosamine and chondroitin. Upon physical 
examination, she was afebrile, normal blood pressure, 
with jaundice and tachycardia (100 bpm). Flacid abdomen, 
not painful upon palpation, no enlarged organs or signs 
of chronic liver disease. The laboratory tests revealed 
abnormal enzyme levels and hyperbilirubinemia, and 
other parameters were unaltered. Serology for viral 
hepatites and autoantibodies were negative. Magnetic 
resonance cholangiography showed no abnormalities. 
Treatment prescribed was rest and withdrawing all 
medications, except hormone replacement for thyroid. 
Among the laboratory tests that were initially 
increased, ALT-GPT dropped from 1,667U/L to 36U/L, and 
AST-GOT from 1,599U/L to 30U/L, after approximately 
7 weeks. Similar recovery was observed in total bilirubin 
levels, that reduced from 9.0mg/dL to 1.24mg/dL, due 
to drop in the direct bilirubin fractions from 8.3mg/dL 
to 0.73mg/dL. 
DISCUSSION
Hypericum perforatum, or St John´s wort, is broadly 
distributed in many countries and indicated for 
treatment of mild to moderate depression,(9) anxiety, 
insomnia and nevralgia, and its antiviral, antibacterial 
and photosensitizing activities are well known. There 
is no consensus about its antidepressant action,(10) but 
in some countries, including Germany, it represents 
roughly 25% of all prescriptions of this drug class, 
and it is available in compounding pharmacies, and 
phytotherapeutic and natural product shops.
Acting on cytochrome P450, it might reduce the serum 
levels of some drugs or increase their clearance.(3,5) The 
interaction with other drugs favors its adverse effects,(11,12) 
including hepatotoxicity, as already mentioned.(13) 
In the case presented, it was crucial to investigate 
other causes of acute hepatic disease, such as serology 
for hepatitis A, B and C viruses; autoimmunity despite 
her age, evaluated by the initial measurement of serum 
globulins; as well as imaging methods, particularly magnetic 
resonance cholangiography to exclude abnormalities in 
the intrahepatic and extrahepatic biliary ducts.
The laboratory follow-up of the patient showed 
progressive drop in enzyme and bilirubin levels, after 
discontinuing the drugs suspected of being hepatotoxic, 
and the tests returned to normal levels with no intercurrent 
events.
The second herbaceous product – copaiba – is an 
oil-resin extracted from the trunk of Copaifera ssp., and 
is often used in the Brazilian Northern and Northeastern 
regions as an anti-inflammatory agent. Its hepatotoxic 
effect is subject to discussion(14) and its participation, 
together with another phytotherapeutic drug, is not 
excluded in triggering the described medication-induced 
acute hepatitis.
CONCLUSION
This report aimed to emphasize the importance of 
a detailed clinical history, with special attention 
given to medications taken by patients. The apparent 
innocuous features of natural products allow their free 
consumption, and they are not considered as a risk to 
developing diseases. The same reason makes patients 
omit this piece of information in their clinical history. 
Hence, it is up to physicians to ask about all drugs the 
patient is taking now or has taken recently, to investigate 
the toxicity characteristics, particularly when there is 
interaction with other medications, because there will 
be more data for making presumptive and differential 
diagnoses. This is valid when exploring diseases and 
it is even more important in cases of liver conditions, 
since this organ has special sensibility in responding 
to the chemical action of certain drugs. In the present 
case, special emphasis was given to the use of copaiba 
associated to Hypericum. 
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